Exploring the role of this acute phase responses protein as an for the diagnosis, monitoring, and treatment of ischemic and inflammatory cardiovascular disease
Despite diagnostic and therapeutic advances, the rate of event recurrence is still relatively high a...
Cardiovascular diseases are gaining a dubious distinction of becoming the leading cause of death. Th...
Recent evidence has shown that inflammation plays a pivotal role in the inception and progression of...
AbstractInflammation is widely considered to be an important contributing factor of the pathophysiol...
Update on C-reactive protein as a risk marker in cardiovascular disease. Atherosclerosis is characte...
Raed Osman1, Philippe L L’Allier1, Nader Elgharib, Jean-Claude TardifDepartment of Medicine, M...
A project presented to the Department of Physician Assistant of Wichita State University in partial ...
Human C-reactive protein (CRP) is an acute phase protein which arises rapidly and tremendously in se...
It is now recognized that inflammatory processes regulate all stages of atherosclerosis, from diseas...
C-reactive protein (CRP) is a marker of systemic inflammation, and it has been implicated in the pat...
It is known that the key mediator of acute phase response and marker of inflammation is C-reactive p...
Atherosclerosis is a chronic inflammatory disease. Several circulating inflammatory markers have bee...
Ischemic heart disease (CHD) is a set of pathophysiological states, disorders of blood flow and oxyg...
The American Heart Association estimates that by 2035 over 130 million or 45.1 percent of the Americ...
Convincing evidence indicates that both local inflam-mation in the arterial wall and systemic signs ...
Despite diagnostic and therapeutic advances, the rate of event recurrence is still relatively high a...
Cardiovascular diseases are gaining a dubious distinction of becoming the leading cause of death. Th...
Recent evidence has shown that inflammation plays a pivotal role in the inception and progression of...
AbstractInflammation is widely considered to be an important contributing factor of the pathophysiol...
Update on C-reactive protein as a risk marker in cardiovascular disease. Atherosclerosis is characte...
Raed Osman1, Philippe L L’Allier1, Nader Elgharib, Jean-Claude TardifDepartment of Medicine, M...
A project presented to the Department of Physician Assistant of Wichita State University in partial ...
Human C-reactive protein (CRP) is an acute phase protein which arises rapidly and tremendously in se...
It is now recognized that inflammatory processes regulate all stages of atherosclerosis, from diseas...
C-reactive protein (CRP) is a marker of systemic inflammation, and it has been implicated in the pat...
It is known that the key mediator of acute phase response and marker of inflammation is C-reactive p...
Atherosclerosis is a chronic inflammatory disease. Several circulating inflammatory markers have bee...
Ischemic heart disease (CHD) is a set of pathophysiological states, disorders of blood flow and oxyg...
The American Heart Association estimates that by 2035 over 130 million or 45.1 percent of the Americ...
Convincing evidence indicates that both local inflam-mation in the arterial wall and systemic signs ...
Despite diagnostic and therapeutic advances, the rate of event recurrence is still relatively high a...
Cardiovascular diseases are gaining a dubious distinction of becoming the leading cause of death. Th...
Recent evidence has shown that inflammation plays a pivotal role in the inception and progression of...
DOI
Add to ORKG